316 related articles for article (PubMed ID: 17018279)
1. Measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor.
Armstrong N; Jasti J; Beich-Frandsen M; Gouaux E
Cell; 2006 Oct; 127(1):85-97. PubMed ID: 17018279
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of glutamate receptor desensitization.
Sun Y; Olson R; Horning M; Armstrong N; Mayer M; Gouaux E
Nature; 2002 May; 417(6886):245-53. PubMed ID: 12015593
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms for ligand binding to GluR0 ion channels: crystal structures of the glutamate and serine complexes and a closed apo state.
Mayer ML; Olson R; Gouaux E
J Mol Biol; 2001 Aug; 311(4):815-36. PubMed ID: 11518533
[TBL] [Abstract][Full Text] [Related]
4. Microsecond-to-millisecond conformational dynamics demarcate the GluR2 glutamate receptor bound to agonists glutamate, quisqualate, and AMPA.
Valentine ER; Palmer AG
Biochemistry; 2005 Mar; 44(9):3410-7. PubMed ID: 15736951
[TBL] [Abstract][Full Text] [Related]
5. Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2.
Frandsen A; Pickering DS; Vestergaard B; Kasper C; Nielsen BB; Greenwood JR; Campiani G; Fattorusso C; Gajhede M; Schousboe A; Kastrup JS
Mol Pharmacol; 2005 Mar; 67(3):703-13. PubMed ID: 15591246
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for partial agonist action at ionotropic glutamate receptors.
Jin R; Banke TG; Mayer ML; Traynelis SF; Gouaux E
Nat Neurosci; 2003 Aug; 6(8):803-10. PubMed ID: 12872125
[TBL] [Abstract][Full Text] [Related]
7. Probing the function, conformational plasticity, and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted willardiines and GluR2 S1S2 in the crystal.
Jin R; Gouaux E
Biochemistry; 2003 May; 42(18):5201-13. PubMed ID: 12731861
[TBL] [Abstract][Full Text] [Related]
8. Distinct structural features of cyclothiazide are responsible for effects on peak current amplitude and desensitization kinetics at iGluR2.
Hald H; Ahring PK; Timmermann DB; Liljefors T; Gajhede M; Kastrup JS
J Mol Biol; 2009 Sep; 391(5):906-17. PubMed ID: 19591837
[TBL] [Abstract][Full Text] [Related]
9. Structure and different conformational states of native AMPA receptor complexes.
Nakagawa T; Cheng Y; Ramm E; Sheng M; Walz T
Nature; 2005 Feb; 433(7025):545-9. PubMed ID: 15690046
[TBL] [Abstract][Full Text] [Related]
10. Probing the ligand binding domain of the GluR2 receptor by proteolysis and deletion mutagenesis defines domain boundaries and yields a crystallizable construct.
Chen GQ; Sun Y; Jin R; Gouaux E
Protein Sci; 1998 Dec; 7(12):2623-30. PubMed ID: 9865957
[TBL] [Abstract][Full Text] [Related]
11. A molecular envelope of the ligand-binding domain of a glutamate receptor in the presence and absence of agonist.
Abele R; Svergun D; Keinänen K; Koch MH; Madden DR
Biochemistry; 1999 Aug; 38(34):10949-57. PubMed ID: 10460150
[TBL] [Abstract][Full Text] [Related]
12. Identification of a site in GluR1 and GluR2 that is important for modulation of deactivation and desensitization.
Leever JD; Clark S; Weeks AM; Partin KM
Mol Pharmacol; 2003 Jul; 64(1):5-10. PubMed ID: 12815155
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of agonist recognition by the ligand-binding core of the ionotropic glutamate receptor 4.
Kasper C; Frydenvang K; Naur P; Gajhede M; Pickering DS; Kastrup JS
FEBS Lett; 2008 Dec; 582(29):4089-94. PubMed ID: 19022251
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the kainate receptor GluR5 ligand-binding core in complex with (S)-glutamate.
Naur P; Vestergaard B; Skov LK; Egebjerg J; Gajhede M; Kastrup JS
FEBS Lett; 2005 Feb; 579(5):1154-60. PubMed ID: 15710405
[TBL] [Abstract][Full Text] [Related]
15. Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant.
Johnson WD; Parandaman V; Onaivi ES; Taylor RE; Akinshola BE
Brain Res; 2008 Jul; 1222():18-30. PubMed ID: 18585685
[TBL] [Abstract][Full Text] [Related]
16. Structural aspects of AMPA receptor activation, desensitization and deactivation.
Hansen KB; Yuan H; Traynelis SF
Curr Opin Neurobiol; 2007 Jun; 17(3):281-8. PubMed ID: 17419047
[TBL] [Abstract][Full Text] [Related]
17. A tetrazolyl-substituted subtype-selective AMPA receptor agonist.
Vogensen SB; Frydenvang K; Greenwood JR; Postorino G; Nielsen B; Pickering DS; Ebert B; Bølcho U; Egebjerg J; Gajhede M; Kastrup JS; Johansen TN; Clausen RP; Krogsgaard-Larsen P
J Med Chem; 2007 May; 50(10):2408-14. PubMed ID: 17455929
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, theoretical and structural analyses, and enantiopharmacology of 3-carboxy homologs of AMPA.
Brehm L; Greenwood JR; Sløk FA; Holm MM; Nielsen B; Geneser U; Stensbøl TB; Bräuner-Osborne H; Begtrup M; Egebjerg J; Krogsgaard-Larsen P
Chirality; 2004 Aug; 16(7):452-66. PubMed ID: 15236343
[TBL] [Abstract][Full Text] [Related]
19. Xenopus laevis oocytes endogenously express all subunits of the ionotropic glutamate receptor family.
Schmidt C; Klein C; Hollmann M
J Mol Biol; 2009 Jul; 390(2):182-95. PubMed ID: 19445955
[TBL] [Abstract][Full Text] [Related]
20. A binding site tyrosine shapes desensitization kinetics and agonist potency at GluR2. A mutagenic, kinetic, and crystallographic study.
Holm MM; Naur P; Vestergaard B; Geballe MT; Gajhede M; Kastrup JS; Traynelis SF; Egebjerg J
J Biol Chem; 2005 Oct; 280(42):35469-76. PubMed ID: 16103115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
